IN2013MU01225A - - Google Patents

Info

Publication number
IN2013MU01225A
IN2013MU01225A IN1225MU2013A IN2013MU01225A IN 2013MU01225 A IN2013MU01225 A IN 2013MU01225A IN 1225MU2013 A IN1225MU2013 A IN 1225MU2013A IN 2013MU01225 A IN2013MU01225 A IN 2013MU01225A
Authority
IN
India
Prior art keywords
compositions
sitagliptin
metformin
salts
present
Prior art date
Application number
Inventor
Girish Kumar Jain
Venkataramana Naidu
Atul Patil
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to US14/766,939 priority Critical patent/US20150366863A1/en
Priority to EP14722341.6A priority patent/EP2996680A1/en
Priority to IN1225MU2013 priority patent/IN2013MU01225A/en
Priority to PCT/IB2014/060081 priority patent/WO2014170770A1/en
Publication of IN2013MU01225A publication Critical patent/IN2013MU01225A/en
Priority to ZA2015/05916A priority patent/ZA201505916B/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention provides solid oral pharmaceutical compositions comprising combination of metformin and sitagliptin or salts thereof. In particular, the present invention relates to a pharmaceutical composition comprising metformin and sitagliptin or salts thereof which is devoid of any glidant. The invention also includes process of preparing such compositions and method of use of such compositions for treating type II diabetes.
IN1225MU2013 2013-03-28 2014-03-24 IN2013MU01225A (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US14/766,939 US20150366863A1 (en) 2013-03-28 2014-03-24 Solid oral pharmaceutical compositions comprising fixed dose combination of metformin and sitagliptin or salts thereof
EP14722341.6A EP2996680A1 (en) 2013-03-28 2014-03-24 Solid oral pharmaceutical compositions comprising fixed dose combination of metformin and sitagliptin or salts thereof
IN1225MU2013 IN2013MU01225A (en) 2013-03-28 2014-03-24
PCT/IB2014/060081 WO2014170770A1 (en) 2013-03-28 2014-03-24 Solid oral pharmaceutical compositions comprising fixed dose combination of metformin and sitagliptin or salts thereof
ZA2015/05916A ZA201505916B (en) 2013-03-28 2015-08-17 Solid oral pharmaceutical compositions comprising fixed dose combination of metformin and sitagliptin or salts thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1225MU2013 IN2013MU01225A (en) 2013-03-28 2014-03-24

Publications (1)

Publication Number Publication Date
IN2013MU01225A true IN2013MU01225A (en) 2015-04-17

Family

ID=54395598

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1225MU2013 IN2013MU01225A (en) 2013-03-28 2014-03-24

Country Status (1)

Country Link
IN (1) IN2013MU01225A (en)

Similar Documents

Publication Publication Date Title
PH12021550792A1 (en) 2-(morpholin-4-yl)-1,7-naphthyridines
PH12016501581A1 (en) Benzimidazol-2-amines as midh1 inhibitors
PH12015500387A1 (en) Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis b
MX2015011229A (en) Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis b.
PH12016501807A1 (en) Novel compounds
PH12017500533A1 (en) 1-alkyl-6-oxo-1, 6-dihydropyridin-3-yl compounds and use as sgrm modulators
TW201613864A (en) Novel compounds
BR112017005242A2 (en) compound, pharmaceutical composition, and compound for use.
MX2014010433A (en) Novel crystalline form of sitagliptin sulfate.
PH12016501814A1 (en) Inhibitors of the wnt signalling pathways
MX2016009667A (en) Crystal form a of compound a monobenzoate and preparation method thereof and pharmaceutical composition comprising same.
EA033769B9 (en) Selected amide of -hydroxybutyric acid and uses thereof in the treatment of alcohol misuse
EA201491581A1 (en) ВЕЗИКУЛЯРНЫЕ КОМПОЗИЦИИ
PH12017500323A1 (en) P38 map kinase inhibiting indanyl urea compounds
IN2013MU01225A (en)
IN2013MU01223A (en)
IN2013MU01224A (en)
IN2013MU01222A (en)
EA033077B1 (en) Pharmaceutical composition containing 13 triglycerides, and preparations and use thereof
IN2014DN10683A (en)
IN2013MU03427A (en)
IN2013MU01158A (en)
IN2013MU01159A (en)
IN2014MU00184A (en)
IN2014MU00185A (en)